Director/PDMR Shareholding

RNS Number : 8185X

Deltex Medical Group PLC

30 June 2008

 



Deltex Medical Group plc

Directors' Shareholdings and Issue of Equity

30 June 2008 Deltex Medical Group plc ('Deltex Medical' or the 'Company'), the UK's leading haemodynamic monitoring company, announces that it has today issued a total of 413,746 new ordinary shares in the Company to certain non-executive directors and a former non-executive director of the Company at a price of 19.25 pence per share. This issue is as announced on 25 January 2008, having been previously conditional on approvals which were granted at the Company's Annual General Meeting on 13 May 2008.

In addition to the above, the Company has today issued a total of 538,279 new ordinary shares in the Company to certain non-executive directors at a price of 18.50 pence per share and to certain advisors of the Company at an average price of 18.70 pence per share.

The three non-executive directors named below have elected to take shares in lieu of a cash payment as remuneration for their services to the Company for the three month period ended 31 March 2008. In addition, certain of the Company's advisors have elected to take shares in lieu of cash payment for their services to the Company.

Accordingly, application has been made for the above shares to be admitted to trading on AIM. The shares rank pari passu with the existing issued shares of the Company and dealings are expected to commence on 4 July 2008. Following the issue of these new shares the Company has a total of 100,359,629 ordinary shares in issue.

Following this issue, the directors' beneficial interests are as follows:

Name of Director	Number of new ordinary shares issued in lieu of fees (as previously announced)	Number of new ordinary shares issued in lieu of fees (as announced above)	Holding of shares following issue of new ordinary shares	% of enlarged issued share capital
Nigel Keen	162,338	33,784	3,861,536	3.85%
Dr Edwin Snape (1)	116,883	24,324	6,764,610	6.74%
Andy Hill	-	-	179,334	0.18%
Ewan Phillips	-	-	977,156	0.97%
George Flouty	-	-	343,984	0.34%
Sir Duncan Nichol	91,169	18,973	219,103	0.22%
Juilan Cazalet			1,250,000	1.25%
Total	370,390	77,081	13,595,723	13.55%

(1)    Includes shares held as a director of New England Partners and associated companies.

 For further information, please contact:-

Deltex Medical Group plc                            01243 774 837
Nigel Keen, Chairman                 
Andy Hill, Chief Executive            
Ewan Phillips, Finance Director        

Charles Stanley Securities (Nominate Advisor)                0207 953 2000  Philip Davies

Russell Cook

 

END

 

 

RDSIIFVRRVIIVIT